Skip to main content
. Author manuscript; available in PMC: 2014 Aug 27.
Published in final edited form as: Oncogene. 2013 Mar 11;33(9):1181–1189. doi: 10.1038/onc.2013.42

Table 1.

Demographic and clinical characteristics of 76 NSCLC patients and the association with miR-486-5p expression in tumor tissue specimens

Characteristics Number of cases (%) Median expression of miR-486-5p (mean±s.d.) P
Age, year
 ≥69 46 (60.5) 0.03182±0.03206 0.18608
 <69 30 (39.5) 0.02165±0.00276
Gender
 Male 56 (73.7) 0.03083±0.04577 0.26550
 Female 20 (26.3) 0.02017±0.03556
Histology
 Adenocarcinomas 39 (51.3) 0.02816±0.04354 0.19643
 Squamous cell carcinomas 37 (48.7) 0.02253±0.02902
Smokersa
 Yes 69 (90.8) 0.02126±0.03763 0.16601
 No 7 (9.2) 0.03015±0.02010
T-status
 1a 13 (17.1) 0.03557±0.04555 0.34540
 1b 9 (11.8) 0.03106±0.02678
 2 34 (44.8) 0.03264±0.04135
 3 15 (19.7) 0.03936±0.03584
 4 5 (6.6) 0.03309±0.03276
N-statusb
 No 30 (39.5) 0.02829±0.05080 0.00190
 Yes 46 (60.5) 0.01503±0.01916
Stage
 I 19 (25.0) 0.07665±0.04979 0.00010
 II 33 (43.4) 0.02830±0.01585
 III 24 (31.6) 0.01008±0.00746

Abbreviation: NSCLC, non-small-cell lung cancer.

a

Smokers were defined as persons who had smoked a 20 pack year, or greater.

b

Lymph node status was classified as N0, N1, N2 and N3. In the present study, N1, N2 and N3 are considered to be ‘Yes’, whereas N0 is considered as ‘No’.